Osteoporosis — Bone Disease in Chronic Pancreatitis: A Complex Phenomenon
Citation(s)
Daniell HW Hypogonadism in men consuming sustained-action oral opioids. J Pain. 2002 Oct;3(5):377-84. doi: 10.1054/jpai.2002.126790.
Daniell HW Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain. 2008 Jan;9(1):28-36. doi: 10.1016/j.jpain.2007.08.005. Epub 2007 Nov 1.
Duggan SN, Smyth ND, Murphy A, Macnaughton D, O'Keefe SJ, Conlon KC High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014 Feb;12(2):219-28. doi: 10.1016/j.cgh.2013.06.016. Epub 2013 Jul 12.
Gachago C, Draganov PV Pain management in chronic pancreatitis. World J Gastroenterol. 2008 May 28;14(20):3137-48. doi: 10.3748/wjg.14.3137.
Haaber AB, Rosenfalck AM, Hansen B, Hilsted J, Larsen S Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int J Pancreatol. 2000 Feb;27(1):21-7. doi: 10.1385/IJGC:27:1:21.
Haworth CS Impact of cystic fibrosis on bone health. Curr Opin Pulm Med. 2010 Nov;16(6):616-22. doi: 10.1097/MCP.0b013e32833e2e94.
Klapdor S, Richter E, Klapdor R Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Res. 2012 May;32(5):1991-8.
Krupa-Kozak U Pathologic bone alterations in celiac disease: etiology, epidemiology, and treatment. Nutrition. 2014 Jan;30(1):16-24. doi: 10.1016/j.nut.2013.05.027.
Lankisch PG, Lohr-Happe A, Otto J, Creutzfeldt W Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion. 1993;54(3):148-55. doi: 10.1159/000201029.
Li L, Setoguchi S, Cabral H, Jick S Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database. Am J Epidemiol. 2013 Aug 15;178(4):559-69. doi: 10.1093/aje/kwt013. Epub 2013 May 2.
Mann ST, Stracke H, Lange U, Klor HU, Teichmann J Vitamin D3 in patients with various grades of chronic pancreatitis, according to morphological and functional criteria of the pancreas. Dig Dis Sci. 2003 Mar;48(3):533-8. doi: 10.1023/a:1022540816990.
Nusrat S, Yadav D, Bielefeldt K Pain and opioid use in chronic pancreatitis. Pancreas. 2012 Mar;41(2):264-70. doi: 10.1097/MPA.0b013e318224056f.
Yadav D, Lowenfels AB The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013 Jun;144(6):1252-61. doi: 10.1053/j.gastro.2013.01.068.
Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol. 2011 Dec;106(12):2192-9. doi: 10.1038/ajg.2011.328. Epub 2011 Sep 27. Erratum In: Am J Gastroenterol. 2011 Dec;106(12):2209.
Yadav D, Whitcomb DC The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol. 2010 Mar;7(3):131-45. doi: 10.1038/nrgastro.2010.6. Epub 2010 Feb 2.
Bone Disease in Chronic Pancreatitis: A Complex Phenomenon
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
